jtp 2942 has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hojo, S; Nakayama, H; Narita, K; Tamura, A; Yamaguchi, T; Yonemori, F | 1 |
| Katayama, Y; Katsumata, T; Muramatsu, H; Nakamura, H; Nishiyama, Y; Ootori, T; Seta, T; Terashi, A | 1 |
2 other study(ies) available for jtp 2942 and Brain Ischemia
| Article | Year |
|---|---|
Effect of JTP-2942, a novel thyrotropin-releasing hormone analog, on motor deficits after chronic focal cerebral ischemia in rats.
Topics: Animals; Avoidance Learning; Brain; Brain Ischemia; Cerebral Infarction; Chronic Disease; Male; Motor Activity; Nervous System; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone | 2000 |
Effect of long-term administration of JTP-2942, a novel thyrotropin-releasing hormone analogue, on neurological outcome, local cerebral blood flow and glucose utilization in a rat focal cerebral ischemia.
Topics: Animals; Brain; Brain Infarction; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Glucose; Male; Movement Disorders; Neurons; Rats; Rats, Wistar; Reperfusion Injury; Respiratory Physiological Phenomena; Thyrotropin-Releasing Hormone | 2001 |